Publication
4/15/2005
Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapy.
Wang L, Calcedo R, Nichols TC, Bellinger DA, Dillow A, Verma IM, Wilson JM
Blood
Publication
4/01/2005
Gene transfer into skeletal muscle using novel AAV serotypes.
Louboutin JP, Wang L, Wilson JM
The Journal Of Gene Medicine
Publication
4/01/2005
Proteasome inhibition enhances AAV-mediated transgene expression in human synoviocytes in vitro and in vivo.
Jennings K, Miyamae T, Traister R, Marinov A, Katakura S, Sowders D, Trapnell B, Wilson JM, Gao G, Hirsch R
Molecular Therapy : The Journal Of The American Society Of Gene Therapy
Publication
4/01/2005
Nonhuman primate models for diabetic ocular neovascularization using AAV2-mediated overexpression of vascular endothelial growth factor.
Lebherz C, Maguire AM, Auricchio A, Tang W, Aleman TS, Wei Z, Grant R, Cideciyan AV, Jacobson SG, Wilson JM, Bennett J
Diabetes
Publication
4/01/2005
SARS vaccine: progress and challenge.
Zhi Y, Wilson JM, Shen H
Cellular & Molecular Immunology
Publication
3/15/2005
Use of chimeric adenoviral vectors to assess capsid neutralization determinants.
Roy S, Clawson DS, Calcedo R, Lebherz C, Sanmiguel J, Wu D, Wilson JM
Virology